IN8bio Inc.

NASDAQ: INAB · Real-Time Price · USD
2.35
-0.05 (-2.08%)
At close: Aug 15, 2025, 3:59 PM
2.37
0.85%
After-hours: Aug 15, 2025, 04:10 PM EDT

IN8bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.12M 21.28M 18.18M 37.02M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
266K 256K 252K 251K
Other Long-Term Assets
275K 255K 381K 158K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
298K 270K 232K 52K
Total Current Assets
12.58M 24.63M 22.23M 38.98M
Property-Plant & Equipment
7.83M 8.57M 10.3M 2.83M
Goodwill & Intangibles
n/a n/a 126K n/a
Total Long-Term Assets
8.37M 9.08M 10.8M 3.24M
Total Assets
20.94M 33.71M 33.04M 42.22M
Account Payables
389K 924K 2.09M 395K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.65M n/a n/a 626K
Other Current Liabilities
1.05M 1.67M 1.46M 300K
Total Current Liabilities
3.08M 5.39M 5.82M 2.26M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
3.38M 3.38M 4.49M 1.78M
Total Liabilities
6.47M 8.77M 10.31M 4.04M
Total Debt
5.03M 4.89M 5.87M 2.41M
Common Stock
7K 4K 3K 2K
Retained Earnings
-121.66M -91.22M -61.21M -32.69M
Comprehensive Income
n/a n/a n/a -42.22M
Shareholders Equity
14.48M 24.94M 22.73M 38.18M
Total Investments
266K 256K 252K 251K